Related references
Note: Only part of the references are listed.Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial
Steve Cunningham et al.
LANCET RESPIRATORY MEDICINE (2021)
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
D. M. Weinreich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R. Libster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
Paul-Albert Koenig et al.
SCIENCE (2021)
Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants
Rui Wang et al.
COMMUNICATIONS BIOLOGY (2021)
Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice
Phillip Pymm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
A potent neutralizing nanobody against SARS-CoV-2 with inhaled delivery potential
Junwei Gai et al.
MEDCOMM (2021)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
Daniel Wrapp et al.
CELL (2020)
Identification of Human Single-Domain Antibodies against SARS-CoV-2
Yanling Wu et al.
CELL HOST & MICROBE (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2
Rocktotpal Konwarh
FRONTIERS IN IMMUNOLOGY (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost et al.
NATURE (2020)
Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures
Nikolai Eroshenko et al.
NATURE BIOTECHNOLOGY (2020)
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Jiangdong Huo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Recombinant expression of nanobodies and nanobody-derived immunoreagents
Ario de Marco
PROTEIN EXPRESSION AND PURIFICATION (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
Zhe Lv et al.
SCIENCE (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein
Xiaoyi Fan et al.
NATURE COMMUNICATIONS (2020)
COVID-19 antibodies on trial
Linda J. Saif et al.
NATURE BIOTECHNOLOGY (2020)
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
M. Alejandra Tortorici et al.
SCIENCE (2020)
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
Leo Hanke et al.
NATURE COMMUNICATIONS (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein (vol 180, 281.e1, 2020)
Alexandra C. Walls et al.
CELL (2020)
'IT WILL CHANGE EVERYTHING': DEEPMIND'S AI MAKES GIGANTIC LEAP IN SOLVING PROTEIN STRUCTURES
Ewen Callaway
NATURE (2020)
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike
Michael Schoof et al.
SCIENCE (2020)
Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice
Yushu Joy Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Protein structure prediction using multiple deep neural networks in the 13th Critical Assessment of Protein Structure Prediction (CASP13)
Andrew W. Senior et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2019)
Nanobody: outstanding features for diagnostic and therapeutic applications
J. -Pablo Salvador et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2019)
Therapeutic application of antibody fragments in autoimmune diseases: current state and prospects
Joao C. Fernandes
DRUG DISCOVERY TODAY (2018)
Recent advances in the selection and identification of antigen-specific nanobodies
Wenshuai Liu et al.
MOLECULAR IMMUNOLOGY (2018)
Yeast surface display platform for rapid discovery of conformationally selective nanobodies
Conor McMahon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Yeast surface display platform for rapid discovery of conformationally selective nanobodies
Conor McMahon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
The structural basis of nanobody unfolding reversibility and thermoresistance
Patrick Kunz et al.
SCIENTIFIC REPORTS (2018)
RosettaAntibodyDesign (RAbD): A general framework for computational antibody design
Jared Adolf-Bryfogle et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2
Wenfei Song et al.
PLOS PATHOGENS (2018)
Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection
V. Stalin Raj et al.
SCIENCE ADVANCES (2018)
Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin
Nick S. Laursen et al.
SCIENCE (2018)
Third generation antibody discovery methods: in silico rational design
Pietro Sormanni et al.
CHEMICAL SOCIETY REVIEWS (2018)
Expression of single-domain antibody in different systems
Yongkang Liu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2018)
GISAID: Global initiative on sharing all influenza data - from vision to reality
Yuelong Shu et al.
EUROSURVEILLANCE (2017)
Selection, characterization, and thermal stabilization of llama single domain antibodies towards Ebola virus glycoprotein
Jinny L. Liu et al.
MICROBIAL CELL FACTORIES (2017)
Massively parallel de novo protein design for targeted therapeutics
Aaron Chevalier et al.
NATURE (2017)
Global analysis of protein folding using massively parallel design, synthesis, and testing
Gabriel J. Rocklin et al.
SCIENCE (2017)
Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization
Anna D. Koromyslova et al.
PLOS PATHOGENS (2017)
Unravelling the Molecular Basis of High Affinity Nanobodies against HIV p24: In Vitro Functional, Structural, and in Silico Insights
Eleanor R. Gray et al.
ACS INFECTIOUS DISEASES (2017)
Evaluation of Nanobody Conjugates and Protein Fusions as Bioanalytical Reagents
Virginia J. Bruce et al.
ANALYTICAL CHEMISTRY (2017)
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
Laurent Detalle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Post-exposure Treatment with Anti-rabies VHH and Vaccine Significantly Improves Protection of Mice from Lethal Rabies Infection
Sanne Terryn et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies
Sandrine Moutel et al.
ELIFE (2016)
Anti-VP6 VHH: An Experimental Treatment for Rotavirus A-Associated Disease
Lucia Maffey et al.
PLOS ONE (2016)
Camelid nanobodies: killing two birds with one stone
Aline Desmyter et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2015)
Development of VHH Antibodies against Dengue Virus Type 2 NS1 and Comparison with Monoclonal Antibodies for Use in Immunological Diagnosis
Aneela Fatima et al.
PLOS ONE (2014)
The Breadth of Cross Sub-Type Neutralisation Activity of a Single Domain Antibody to Influenza Hemagglutinin Can Be Increased by Antibody Valency
Simon E. Hufton et al.
PLOS ONE (2014)
Nanobody-based products as research and diagnostic tools
Thomas De Meyer et al.
TRENDS IN BIOTECHNOLOGY (2014)
An Alpaca Nanobody Inhibits Hepatitis C Virus Entry and Cell-to-Cell Transmission
Alexander W. Tarr et al.
HEPATOLOGY (2013)
Nanobodies®: New ammunition to battle viruses
Peter Vanlandschoot et al.
ANTIVIRAL RESEARCH (2011)
Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection
Lorena Itati Ibanez et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
In vitro antiviral activity of single domain antibody fragments against poliovirus
Bert Thys et al.
ANTIVIRAL RESEARCH (2010)
Production, characterization and in vitro testing of HBcAg-specific VHH intrabodies
Benedikte Serruys et al.
JOURNAL OF GENERAL VIROLOGY (2010)
CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells
Sven Jahnichen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Inhaling medicines: delivering drugs to the body through the lungs
John S. Patton et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Antigen binding and solubility effects upon veneering of a camel VHH in framework-2 to the mimic a VH
K Conrath et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Large-scale co-evolution analysis of protein structural interlogues using the global protein structural interactome map (PSIMAP)
WK Kim et al.
BIOINFORMATICS (2004)
Single-domain antibody fragments with high conformational stability
M Dumoulin et al.
PROTEIN SCIENCE (2002)
Share Paper
